We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generics Will Find it Harder to Implement REMS Reforms, AAM Says
Generics Will Find it Harder to Implement REMS Reforms, AAM Says
The FDA’s proposed guidance on Risk Evaluation Mitigation Strategies will be much easier for brand-name drugmakers to implement than for generic manufacturers, the Association for Accessible Medicines says.